A STATISTICAL AND CLINICAL STUDY ON MALIGNANT TUMORS OF THE UPPER URINARY TRACT AT OKAYAMA UNIVERSITY HOSPITAL

According to the “Statistics of mortalities of malignant neoplasm” by the Japanese Welfare Mimistry, malignant tumors of the upper urinary tract are increasing in number. One hunderd and four cases of renal cell carcinoma, 48 cases of renal pelvic tumor, and 34 cases of ureteral tumor treated in our...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nippon Hinyokika Gakkai zasshi 1981, Vol.72(2), pp.166-177
Hauptverfasser: Kaneshige, Tetsuzo, Asahi, Toshihiko, Ozaki, Yujiro, Yoshimoto, Jun, Suyama, Bunzo, Tsushima, Tomoyasu, Matsumura, Yosuke, Ohmori, Hiroyuki
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:According to the “Statistics of mortalities of malignant neoplasm” by the Japanese Welfare Mimistry, malignant tumors of the upper urinary tract are increasing in number. One hunderd and four cases of renal cell carcinoma, 48 cases of renal pelvic tumor, and 34 cases of ureteral tumor treated in our department from 1955 to 1977 were followed through 1979. The actual 5-year survival rate was 49% for renal pelvic tumor, 40% for renal cell carcinoma and 34% for ureteral tumor. The actual survival rate for high stage (P3+P4) renal cell carcinomas was 24%, as compared to 66% for low stage (P1+P2) renal cell carcinomas. The prognosis of high stage group of renal cell carcinomas treated with adjuvant therapy (mainly radiation therapy) was better than that without it. The actual survival rate for high grade (G3+G4) renal pelvic tumor was 36%, as compared to 77% for low grade (G1+G2) renal pelvic tumor. Concerning the high grade group, the prognosis of the group treated with operation alone was the best. The prognosis of the ureteral tumors was poor, and 5 of 6 patients who lived more than 5 years were treated with operation alone. On analysis of these results, we noted that ESR, RBC counts and α2-globulin are parameters to be considered in developing a prognosis.
ISSN:0021-5287
1884-7110
DOI:10.5980/jpnjurol1928.72.2_166